f Drug Discovery and Design through Computational Innovations

References

1. VamathevanJ. ClarkD. CzodrowskiP. DunhamI. FerranE. LeeG. LiB. MadabhushiA. ShahP. SpitzerM. ZhaoS. Applications of machine learning in drug discovery and development.Nat. Rev. Drug Discov.201918646347710.1038/s41573‑019‑0024‑5 30976107
   [Google Scholar]
2. ChenH. EngkvistO. WangY. OlivecronaM. BlaschkeT. The rise of deep learning in drug discovery.Drug Discov. Today20182361241125010.1016/j.drudis.2018.01.039 29366762
   [Google Scholar]
3. GawehnE. HissJ.A. SchneiderG. Deep learning in drug discovery.Mol. Inform.201635131410.1002/minf.201501008 27491648
   [Google Scholar]
4. CummingsM.D. SekharanS. Structure-based macrocycle design in small-molecule drug discovery and simple metrics To identify opportunities for macrocyclization of small-molecule ligands.J. Med. Chem.201962156843685310.1021/acs.jmedchem.8b01985 30860377
   [Google Scholar]
5. SchneiderG. Automating drug discovery.Nat. Rev. Drug Discov.20181729711310.1038/nrd.2017.232 29242609
   [Google Scholar]
6. GimenoA. Ojeda-MontesM. Tomás-HernándezS. Cereto-MassaguéA. Beltrán-DebónR. MuleroM. PujadasG. Garcia-VallvéS. The light and dark sides of virtual screening: What is there to know?Int. J. Mol. Sci.2019206137510.3390/ijms20061375 30893780
   [Google Scholar]
7. WillemsH. De CescoS. SvenssonF. Computational chemistry on a budget: Supporting drug discovery with limited resources.J. Med. Chem.20206318101581016910.1021/acs.jmedchem.9b02126 32298123
   [Google Scholar]
8. GawriljukV.O. ZinP.P.K. PuhlA.C. ZornK.M. FoilD.H. LaneT.R. HurstB. TavellaT.A. CostaF.T.M. LakshmananeP. BernatchezJ. GodoyA.S. OlivaG. Siqueira-NetoJ.L. MadridP.B. EkinsS. Machine learning models identify inhibitors of SARS-CoV-2.J. Chem. Inf. Model.20216194224423510.1021/acs.jcim.1c00683 34387990
   [Google Scholar]
9. WahlJ. SanderT. Fully automated creation of virtual chemical fragment spaces using the open-source library OpenChemLib.J. Chem. Inf. Model.20216292202221110.1021/acs.jcim.1c01041 35073086
   [Google Scholar]
10. SadybekovA.V. KatritchV. Computational approaches streamlining drug discovery.Nature2023616795867368510.1038/s41586‑023‑05905‑z 37100941
    [Google Scholar]
11. MarkovI.L. Limits on fundamental limits to computation.Nature2014512751314715410.1038/nature13570 25119233
    [Google Scholar]
12. DahlinJ.L. IngleseJ. WaltersM.A. Mitigating risk in academic preclinical drug discovery.Nat. Rev. Drug Discov.201514427929410.1038/nrd4578 25829283
    [Google Scholar]
13. SliwoskiG. KothiwaleS. MeilerJ. LoweE.W.Jr Computational methods in drug discovery.Pharmacol. Rev.201466133439510.1124/pr.112.007336 24381236
    [Google Scholar]
14. JiangH. WangJ. CongW. HuangY. RamezaniM. SarmaA. DokholyanN.V. MahdaviM. KandemirM.T. Predicting protein-ligand docking structure with graph neural network.J. Chem. Inf. Model.202262122923293210.1021/acs.jcim.2c00127 35699430
    [Google Scholar]
15. SegallM. Can we really do computer-aided drug design?J. Comput. Aided Mol. Des.201226112112410.1007/s10822‑011‑9512‑3 22160553
    [Google Scholar]